Liver, Pancreas, Esophagus, Gallbladder

66 Expert Conversations

    66 Expert Conversations
    Esophageal cancer treatment FAQ. Prognosis. When surgery is not beneficial? 11
    ₩0
    GERD anti-reflux surgery often fails after 10 years. PPI medications and esophageal cancer risk. 3
    ₩0
    Does GERD anti-reflux surgery reduce esophageal cancer risks? The risk does not go down to zero. 2
    ₩0
    Dr. Jari Rasanen. Esophageal cancer and Lung cancer expert. Biography. 0
    ₩0
    Most patients with fatty liver disease & NASH do not have symptoms. Alcohol is often not to blame. 17
    ₩0
    FAQ from patients with fatty liver disease. Life quality, prognosis, alcohol use. 15
    ₩0
    Leading drug candidates for NASH therapy. NAFLD, fatty liver disease treatment. 12
    ₩0
    Liver cancer risk and fatty liver disease. Cancer screening in NASH, NAFLD. 10
    ₩0
    Can fatty liver disease be reversed? NAFLD and NASH treatment. 4
    ₩0
    Diagnostic tests for fatty liver disease, NAFLD. FibroScan and MR Elastography. 3
    ₩0
    Gastroesophageal reflux disease and esophageal cancer. 1
    ₩0
    Patient’s story. Metastatic esophageal cancer. Success of double neoadjuvant chemotherapy. 12
    ₩0
    Future in esophageal cancer treatment. Precision medicine. Tumor genome sequencing. 10
    ₩0
    Esophageal carcinoma. Minimally invasive surgery vs. classic surgery. Surgeon’s skill is paramount. 8
    ₩0
    Esophageal carcinoma radiotherapy. ‘East’ vs. ‘West’ differences in radiotherapy use. 7
    ₩0
    Esophageal carcinoma. Neoadjuvant chemotherapy vs. upfront surgery. 6
    ₩0
    Esophageal carcinoma diagnosis. PET CT. Endoscopic ultrasound. Cure at early stage is possible. 5
    ₩0
    Esophageal carcinoma risks and symptoms. ‘East’ vs. ‘West’ differences in esophageal cancer. 4
    ₩0
    How to improve health of your liver? Difficulty to keep low weight. 16
    ₩0
    Future of liver disease treatment. Xenotransplantation of liver. 14
    ₩0
    Coffee reduces risks of liver disease. Coffee and NAFLD prevention. 13
    ₩0
    When new drugs will be approved for fatty liver disease? 11
    ₩0
    Hepatic Stellate Cells cause fatty liver disease. NAFLD and NASH causes. 9
    ₩0
    Food supplements and generic drugs for NASH and NAFLD. 8
    ₩0
    Gut microbiome and fatty liver disease. NAFLD, NASH, and Fecal transplantation. 7
    ₩0
    Genetic tests to find risks for liver disease [NAFLD and NASH]. 6
    ₩0
    How NASH differs from NAFLD. What drives progression to NASH? 5
    ₩0
    Non-obese patients with NAFLD [fatty liver disease]. ‘Lean NASH’. 2
    ₩0
    What is Non-Alcoholic Fatty Liver Disease? NAFLD Diagnostic Criteria. 1
    ₩0
    Dr. Scott L Friedman. Liver disease, NAFLD, NASH Expert. Biography. 0
    ₩0
    Cancer surgery failures and challenges. Ovarian cancer. Eminent cancer surgeon.
    ₩0
    Hypertension in diabetes and in metabolic syndrome. Best treatment options. 2
    ₩0
    Pancreatic cancer screening. Liver cancer screening. 10
    ₩0
    MRI of liver. MRCP of pancreas. MRCP or ERCP? 9
    ₩0
    Chemotherapy selection for metastatic peritoneal cancer. Precision medicine selection. 14
    ₩0
    How to overcome skeptics in work and in life? Leading cancer surgeon explains. 9
    ₩0
    Stage 4 colon cancer. Liver or lung metastases. Locoregional treatment. DEBIRI TACE, IRE, SIRT. 7
    ₩0
    Gallbladder cancer treatment options. 7
    ₩0
    Best surgical treatment for liver cancer. Surgical technique from Japan. 5
    ₩0
    Pancreatic cancer. Quality of life depends on local control of tumor. 4
    ₩0
    Recently viewed Expert Conversations